Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4325783 | 1.00 | ALDH1A1 (0.42) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL791252 | 0.98 | ALDH1A1 (0.43) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL4337065 | 0.96 | SMN1; SMN2 (0.42) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL4337073 | 0.96 | SMN1; SMN2 (0.42) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL4954390 | 0.94 | ALDH1A1 (0.36) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL9202745 | 0.94 | ALDH1A1 (0.36) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL4953613 | 0.94 | ALDH1A1 (0.36) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL6322740 | 0.94 | ALDH1A1 (0.36) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL9214644 | 0.94 | ALDH1A1 (0.36) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 | |
| SCHEMBL4333124 | 0.92 | ALDH1A1 (0.44) | ALDH1A1ALOX15SMN1; SMN2USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1973919-A2 | ONE POT SYNTHESIS OF TETRAZOLE DERIVATIVES OF SIROLIMUS | Abbott Laboratories (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007094886-A2 | ONE POT SYNTHESIS OF TETRAZOLE DERIVATIVES OF SIROLIMUS | ABBOTT LABORATORIES (US) | 2007-08-23 | — | — | WO | disclosed |
| EP-1326603-A1 | COMPOSITION COMPRISING A CATALYST FOR THE DISMUTATION OF SUPEROXIDE AND USE OF THE COMPOSITION FOR PREVENTING AND TREATING HYPOTENSION | Pharmacia Corporation (US) | 2003-07-16 | — | — | EP | disclosed |
| WO-2003024434-A2 | USE OF A SUPEROXIDE DISMUTASE MIMETIC CATALYST IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING AND TREATING HIV-MEDIATED CENTRAL NERVOUS SYSTEM DAMAGE | METAPHORE PHARMACEUTICALS, INC. (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2001019823-A9 | SUBSTITUTED PYRIDINO PENTAAZAMACROCYLE COMPLEXES HAVING SUPEROXIDE DISMUTASE ACTIVITY | MONSANTO CO (US) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002028390-A1 | COMPOSITION COMPRISING A CATALYST FOR THE DISMUTATION OF SUPEROXIDE AND USE OF THE COMPOSITION FOR PREVENTING AND TREATING HYPOTENSION | PHARMACIA CORPORATION (US) | 2002-04-11 | — | — | WO | disclosed |
| EP-0891338-A1 | BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0888115-A1 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| EP-0846003-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1998-06-10 | — | — | EP | disclosed |
| EP-0844886-A2 | BIOCONJUGATES OF MANGANESE COMPLEXES AND THEIR APPLICATION AS CATALYSTS | MONSANTO COMPANY (US) | 1998-06-03 | — | — | EP | disclosed |
| WO-1997033588-A9 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | — | 1997-11-06 | — | — | WO | disclosed |
| WO-1997033588-A1 | IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1997-09-18 | — | — | WO | disclosed |
| WO-1997033877-A1 | BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1997-09-18 | — | — | WO | disclosed |
| WO-1997006830-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1997-02-27 | — | — | WO | disclosed |
| WO-1997006831-A1 | METHODS OF DIAGNOSTIC IMAGE ANALYSIS USING METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS | MONSANTO COMPANY (US) | 1997-02-27 | — | — | WO | disclosed |
| EP-0756495-A1 | DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES | MONSANTO COMPANY (US) | 1997-02-05 | — | — | EP | disclosed |
| EP-0679155-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE. | MONSANTO CO (US) | 1995-11-02 | — | — | EP | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |